Literature DB >> 10334166

Thoracoscopic resection of solitary lung metastases from colorectal cancer is a viable therapeutic option.

T De Giacomo1, E A Rendina, F Venuta, A M Ciccone, G F Coloni.   

Abstract

STUDY
OBJECTIVES: The reported 5-year survival rate after pulmonary metastasectomy from colorectal carcinoma, usually accomplished through thoracotomy or median sternotomy, ranges from 9 to 47%. Video-assisted thoracoscopy (VAT) is employed routinely for many thoracic surgical procedures, but the main concern about this approach for resection of lung metastases is that VAT does not allow complete lung palpation to identify and remove metastases not detected by preoperative radiologic examinations.
DESIGN: In this study, we reviewed our experience with thoracoscopic resection of single peripheral lung metastases from colorectal carcinoma with potentially curative intent. PATIENTS AND
INTERVENTIONS: From July 1992 to September 1998, 24 patients (15 male, 9 female) with a mean age of 56 years, who previously had undergone resection for colorectal carcinoma and had a single limited and peripheral lung lesion identified by high-resolution CT, underwent thoracoscopic wedge resection of the lesions.
RESULTS: No intraoperative complications developed. Three patients had minor postoperative complications successfully treated. In one case, we found a benign lesion, and this patient was excluded from the analysis. In the remaining cases, metastases from colorectal cancer were confirmed. The median follow-up was 29 months, ranging from 3 to 67 months. Thirteen patients (56.5%) developed recurrence of the disease, and 5 of them (21.7%) had local recurrence. Cumulative 5-year survival estimated by Kaplan-Meier method was 49.5%, not really different from the data reported in the literature.
CONCLUSIONS: Thoracoscopic resection of single peripheral lung metastases from colorectal cancer with potentially curative intent seems effective and justified since the ultimate outcome of this highly selected group of patients seems to be not different from that obtained after a more invasive approach.

Entities:  

Mesh:

Year:  1999        PMID: 10334166     DOI: 10.1378/chest.115.5.1441

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

Review 1.  Treatment Options in Oligometastatic Disease: Stereotactic Body Radiation Therapy - Focus on Colorectal Cancer.

Authors:  Aaron T Wild; Yoshiya Yamada
Journal:  Visc Med       Date:  2017-02-03

2.  Evaluation of video-assisted thoracoscopic surgery for pulmonary metastases: 11-years of experience.

Authors:  Shinsuke Saisho; Masao Nakata; Shigeki Sawada; Motohiro Yamashita; Hideyuki Saeki; Akira Kurita; Shigemitsu Takashima
Journal:  Surg Endosc       Date:  2008-04-24       Impact factor: 4.584

3.  Planned pulmonary resection for metastatic pulmonary tumor with video-assisted thoracoscopic surgery using multidetector row angiography.

Authors:  Shunsuke Yamada; Yoshimasa Inoue; Atsushi Suga; Masayuki Iwazaki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-01-12

Review 4.  Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer.

Authors:  Atsuya Takeda; Naoko Sanuki; Etsuo Kunieda
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

5.  Role of stereotactic body radiation therapy for lung metastases from radio-resistant primary tumours.

Authors:  Davide Franceschini; Luca Cozzi; Fiorenza De Rose; Piera Navarria; Ciro Franzese; Tiziana Comito; Cristina Iftode; Angelo Tozzi; Lucia Di Brina; Anna Maria Ascolese; Elena Clerici; Giuseppe D'Agostino; Antonella Fogliata; Marta Scorsetti
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-03       Impact factor: 4.553

6.  Benefits of video-assisted thoracic surgery for repeated pulmonary metastasectomy.

Authors:  Ryoichi Kondo; Kazutoshi Hamanaka; Satoshi Kawakami; Takashi Eguchi; Gaku Saito; Akira Hyougotani; Takayuki Shiina; Makoto Kurai; Kazuo Yoshida
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-10-13

7.  [Surgical therapy of lung metastases-indications, technique, results].

Authors:  A Stier; C-D Heidecke
Journal:  Radiologe       Date:  2004-07       Impact factor: 0.635

8.  Stereotactic body radiotherapy for patients with oligometastases from colorectal cancer: risk-adapted dose prescription with a maximum dose of 83-100 Gy in five fractions.

Authors:  Atsuya Takeda; Naoko Sanuki; Yuichiro Tsurugai; Yohei Oku; Yousuke Aoki
Journal:  J Radiat Res       Date:  2016-03-16       Impact factor: 2.724

9.  Pulmonary metastasectomy in uterine malignancies: outcome and prognostic factors.

Authors:  Marco Anile; Sara Mantovani; Ylenia Pecoraro; Carolina Carillo; Lorenzo Gherzi; Andreina Pagini; Erino Angelo Rendina; Federico Venuta; Daniele Diso
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.